APA

Lakomy R., Poprach A., Bortlicek Z., Melichar B., Chloupkova R., Vyzula R., Zemanova M., Kopeckova K., Svoboda M., Slaby O., Kiss I., Studentova H., Juracek J., Fiala O., Kopecky J., Finek J., Dusek L., Hejduk K. & Buchler T. (20180814). Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. : BMC cancer.

Chicago

Lakomy Radek, Poprach Alexandr, Bortlicek Zbynek, Melichar Bohuslav, Chloupkova Renata, Vyzula Rostislav, Zemanova Milada, Kopeckova Katerina, Svoboda Marek, Slaby Ondrej, Kiss Igor, Studentova Hana, Juracek Jaroslav, Fiala Ondrej, Kopecky Jindrich, Finek Jindrich, Dusek Ladislav, Hejduk Karel and Buchler Tomas. 20180814. Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. : BMC cancer.

Harvard

Lakomy R., Poprach A., Bortlicek Z., Melichar B., Chloupkova R., Vyzula R., Zemanova M., Kopeckova K., Svoboda M., Slaby O., Kiss I., Studentova H., Juracek J., Fiala O., Kopecky J., Finek J., Dusek L., Hejduk K. and Buchler T. (20180814). Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. : BMC cancer.

MLA

Lakomy Radek, Poprach Alexandr, Bortlicek Zbynek, Melichar Bohuslav, Chloupkova Renata, Vyzula Rostislav, Zemanova Milada, Kopeckova Katerina, Svoboda Marek, Slaby Ondrej, Kiss Igor, Studentova Hana, Juracek Jaroslav, Fiala Ondrej, Kopecky Jindrich, Finek Jindrich, Dusek Ladislav, Hejduk Karel and Buchler Tomas. Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. : BMC cancer. 20180814.